Biotechnology Stocks II Performance Guide: Y-mAbs Therapeutics, Inc. (YMAB)
YMAB has no dividends.
Table and Chart of YMAB Performance
See what a $1,000 investment in YMAB is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| YMAB Returns | |
|---|---|
| Start Date | Oct-31-2018 |
| Start Price | $24.56 |
| End Date | May-17-2024 |
| End Price | $11.60 |
| # Prices | 68 |
| Min Date | Oct-31-2022 |
| Min Price | $3.61 |
| Max Date | Nov-30-2020 |
| Max Price | $50.87 |
| Total Return | -52.77% |
| Annualized Return | -12.40% |
| Current Value of $1,000 Purchase | $472 |
| Number Returns | 2,278 |
| Average Return | -23.06% |
| Number Profitable Returns | 696 |
| Percent Profitable Returns | 30.55% |
| Number Unprofitable Returns | 1,582 |
| Percent Unprofitable Returns | 69.45% |
| Profitable to Unprofitable Returns Ratio | 0.44 |
| YMAB Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $509,038,000 |
| Beta | 0.774 | Price to Sales | 7.42 |
| Earnings per Share | $-0.4900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.24 |
| PRICE DATA | |
| 52 Week High | $20.9 |
| 52 Week Low | $4.6 |
| Analyst Target Price | $21.14 |
| 50-Day Moving Average | $14.96 |
| 200-Day Moving Average | $9.6 |
| FINANCIAL DATA | |
| Revenue per Share | $1.935 |
| Revenue | $84,499,000 |
| Profit Margin | -25.6% |
| Return on Equity | -20.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
YMAB Compare Returns with S&P 500
YMAB Trendline Chart
YMAB Moving Average Chart
YMAB Stock Return Map - See Patterns of Gains and Losses
YMAB Stock Returns/Purchase Dates